1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Collidion Acquires CalAsia Pharmaceuticals

M&A Deal Summary

Collidion Acquires CalAsia Pharmaceuticals

On August 2, 2017, Collidion acquired healthcare services company CalAsia Pharmaceuticals

Acquisition Highlights
  • This is Collidion’s 1st transaction in the Healthcare Services sector.
  • This is Collidion’s 1st transaction in the United States.
  • This is Collidion’s 1st transaction in California.

M&A Deal Summary
Date 2017-08-02
Target CalAsia Pharmaceuticals
Sector Healthcare Services
Buyer(s) Collidion
Deal Type Add-on Acquisition
Advisor(s) Pokala Law (Legal)

Target

CalAsia Pharmaceuticals

San Diego, California, United States
CalAsia Pharmaceuticals, Inc. (dba Plex Pharmaceutical) is focused on the treatment of diseases generally caused by protein misfolding: ALS, Parkinson's disease, and cataracts. CalAsia Pharmaceuticals was founded in 2009 and is based in San Diego, California.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Collidion

Santa Rosa, California, United States
Category Company
Founded 2015
Sector Healthcare Services
DESCRIPTION

Collidion, Inc. is a private healthcare company which provides global healthcare through the acquisition, licensing, development, and commercialization of drugs and medical devices for various markets. Collidion was founded in 2015 and is based in Santa Rosa, California.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2017 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal